We also reviewed the current evidence of BDNF dysfunction in AD at gene, mRNA, and protein level and discussed possible involvement in the pathophysiology of AD and potential usefulness in BDNF-targeting therapy (Figure 2). The gene discussed is BDNF; the disease is Alzheimer disease.